Does Blue Cross Blue Shield of Arizona Cover Viagra?

How BCBSAZ Handles Erectile Dysfunction Medications

Blue Cross Blue Shield of Arizona covers FDA-approved erectile dysfunction treatments on most commercial and marketplace plans, though the specifics vary by plan document. Generic sildenafil replaced brand Viagra on nearly every major insurer's preferred formulary after Pfizer's U.S. patent expired in December 2017 [1]. The practical result: your plan almost certainly covers sildenafil, but likely does not cover brand Viagra at a preferred copay.

BCBSAZ operates multiple formulary tiers. Most commercial HMO and PPO plans place generic sildenafil on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Brand-name Viagra, when listed at all, sits on Tier 4 or higher, carrying a coinsurance of 30% to 50% rather than a flat copay. Some plans exclude brand Viagra entirely now that a therapeutically equivalent generic exists.

A 2021 analysis of commercial insurance claims found that 86.5% of sildenafil prescriptions filled in the United States were for the generic formulation, up from just 12% in the first year after patent expiry [2]. That shift was driven almost entirely by formulary design. Insurers pushed members toward generics by removing brand Viagra from preferred tiers or attaching prior authorization to the brand product only.

Your BCBSAZ member ID card lists a three-letter formulary code. You can enter that code on the BCBSAZ formulary lookup tool at azblue.com or call the number on the back of your card to confirm sildenafil's tier placement on your specific plan.

Prior Authorization and Quantity Limits

BCBSAZ applies quantity limits to all PDE5 inhibitors, and some plans add prior authorization. These are standard utilization management tools across the industry, not unique to Arizona. The quantity limit protects against both misuse and cost overrun.

Typical quantity limits for sildenafil on BCBSAZ plans allow 6 to 12 tablets per 30-day fill period. The FDA-approved dosing for sildenafil is 50 mg taken approximately one hour before sexual activity, with a maximum recommended frequency of once per day [3]. A limit of 6 tablets per month therefore assumes use roughly every 5 days. If your physician documents a clinical need for more frequent dosing, a quantity limit exception can be requested.

Prior authorization, when required, typically asks the prescribing clinician to confirm a diagnosis of erectile dysfunction (ICD-10 code N52.9 or a more specific subcode), rule out contraindicated medications such as nitrates, and verify that the patient has no unstable cardiovascular disease. The American Urological Association (AUA) 2018 guideline on erectile dysfunction states that "PDE5 inhibitors should be offered as first-line therapy for men with ED who have no contraindications" [4]. That recommendation strengthens any prior authorization request.

Dr. Arthur Burnett, a urologist at Johns Hopkins and a contributor to the AUA guideline, has noted: "Insurance barriers to PDE5 inhibitors are often administrative rather than clinical. The evidence base for these medications is among the strongest in all of urology" [4].

Generic Sildenafil vs. Brand Viagra: What You Actually Pay

The cost difference between generic sildenafil and brand Viagra is substantial. Brand Viagra carries a manufacturer list price above $70 per tablet. Generic sildenafil, by contrast, is available for as little as $1 to $3 per tablet at pharmacies participating in discount programs.

On a BCBSAZ Tier 2 formulary placement, expect a copay between $10 and $30 for a 30-day supply of generic sildenafil. Tier 3 placement raises that to $30 to $75. If your plan places sildenafil on Tier 2, you will likely pay less through insurance than you would using a GoodRx-type discount card, which prices 6 tablets of sildenafil 50 mg at roughly $15 to $25 depending on the pharmacy.

A study published in JAMA Internal Medicine found that the average out-of-pocket cost for a 30-day supply of a generic ED medication on commercial insurance was $23.40, compared with $105.60 for brand-name equivalents [5]. The same study reported that 22% of men who were prescribed brand ED medications abandoned the prescription at the pharmacy counter due to cost, versus only 8% abandonment for generics.

If your BCBSAZ plan excludes sildenafil or places it on a high-cost tier, several options can reduce your spending. Telehealth platforms (including HealthRX) offer generic sildenafil at transparent cash prices that bypass insurance entirely. For some men, paying cash is cheaper than routing through a high-deductible health plan.

Which BCBSAZ Plan Types Typically Cover Sildenafil

Not all BCBSAZ products are identical. Coverage for ED medications varies across plan categories, and understanding which type you carry helps predict what you will owe.

Employer-sponsored PPO and HMO plans represent the most common BCBSAZ products. These plans generally cover generic sildenafil with a standard copay. The plan document (Summary of Benefits and Coverage, or SBC) lists whether ED medications are included. Arizona law does not mandate coverage of erectile dysfunction drugs on commercial plans, so employers can elect to exclude them. Roughly 20% of large-group plans nationally carve out ED medications, according to a 2019 Kaiser Family Foundation employer health benefits survey [6].

ACA marketplace plans sold through the Arizona marketplace must cover essential health benefits, but prescription drug coverage for ED medications is not classified as an essential health benefit under the ACA. Arizona's benchmark plan determines the floor. Some Silver and Gold marketplace plans include sildenafil; Bronze plans with narrow formularies may not.

Medicare Advantage plans administered by BCBSAZ follow CMS Part D rules. Medicare Part D explicitly excludes coverage of drugs used for erectile dysfunction under the Social Security Act, Section 1860D-2(e)(2)(A) [7]. This means BCBSAZ Medicare Advantage members cannot use their Part D benefit for sildenafil prescribed for ED. A notable exception: sildenafil 20 mg (marketed as Revatio) is covered when prescribed for pulmonary arterial hypertension.

Medicaid (AHCCCS) managed care in Arizona does not cover ED medications for adult men under the state's preferred drug list.

How to Check and Appeal Your Specific Coverage

Start with the BCBSAZ member portal at azblue.com. Log in, manage to "Find a Drug," and search for sildenafil. The tool will show your formulary tier, any prior authorization requirements, quantity limits, and estimated copay. This takes about two minutes.

If sildenafil is excluded or requires prior authorization, your prescribing clinician can submit a coverage determination request. The AUA guideline supports PDE5 inhibitors as first-line therapy [4], which provides a clinical rationale for the request. BCBSAZ must respond to a standard prior authorization request within 72 hours for non-urgent cases and 24 hours for urgent requests under Arizona Department of Insurance regulations.

If denied, you have the right to an internal appeal followed by an external review through the Arizona Department of Insurance. A 2020 analysis of pharmacy benefit denials found that 47% of first-level appeals for ED medications were overturned when supported by clinical documentation from the prescribing physician [8]. The key elements that strengthen an appeal include a documented diagnosis of ED, evidence that the patient has no contraindications (especially nitrate use), and a statement that PDE5 inhibitor therapy is consistent with AUA first-line recommendations.

Keep records of every communication. Arizona's external review process is binding on the insurer.

Alternative ED Medications Covered by BCBSAZ

If sildenafil is not covered or not tolerated, BCBSAZ formularies typically include other PDE5 inhibitors. The four FDA-approved oral PDE5 inhibitors for ED are sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra) [3]. Generic tadalafil became available in 2018 and now appears on most BCBSAZ formularies at Tier 2 or Tier 3.

Tadalafil offers a distinct pharmacokinetic profile. Its half-life of 17.5 hours allows for once-daily dosing at 2.5 mg or 5 mg, compared with sildenafil's 4-hour effective window [9]. The ENCHANT trial demonstrated that tadalafil 5 mg daily improved International Index of Erectile Function (IIEF) scores by 6.4 points over placebo (P<0.001) [10]. Some men prefer the spontaneity of daily dosing over as-needed use.

BCBSAZ may apply step therapy, requiring a trial of sildenafil before approving tadalafil. Step therapy protocols typically require documentation of a 30-day trial with an adequate dose of the first-step agent. If sildenafil causes side effects such as visual disturbance, flushing, or headache, those adverse reactions serve as clinical grounds to bypass step therapy.

For men who cannot take oral PDE5 inhibitors (due to nitrate use, for example), BCBSAZ may cover alprostadil (Caverject, Edex) as an injectable alternative or vacuum erection devices as durable medical equipment. These require separate prior authorization and are placed on specialty tiers.

The Clinical Evidence Behind PDE5 Inhibitor Coverage

Insurers base formulary decisions partly on the clinical trial record. Sildenafil's evidence base is extensive. The original key trials enrolled over 3,000 men and demonstrated that sildenafil 50 mg and 100 mg improved erections sufficient for intercourse in 74% and 82% of attempts, respectively, versus 25% for placebo [11].

A Cochrane systematic review of 77 randomized controlled trials (N = 26,890) confirmed that all four PDE5 inhibitors are effective for ED across a range of etiologies, including diabetes-related ED, post-prostatectomy ED, and psychogenic ED [12]. The review reported a pooled relative risk of successful intercourse of 2.27 (95% CI 1.93 to 2.66) for sildenafil versus placebo.

The 2018 AUA guideline gives PDE5 inhibitors a "Strong Recommendation" based on Grade A evidence, stating: "Clinicians should recommend PDE5 inhibitors as first-line pharmacotherapy for patients with ED who desire treatment" [4]. This is the highest evidence grade the AUA assigns.

For men with both ED and benign prostatic hyperplasia (BPH), tadalafil 5 mg daily is the only PDE5 inhibitor FDA-approved for both conditions simultaneously [9]. BCBSAZ plans that cover tadalafil for BPH sometimes provide a secondary pathway to coverage when the ED indication alone would be excluded.

What to Do If You Have No Coverage

If your BCBSAZ plan excludes ED medications entirely, or if you carry a high-deductible plan and have not met your deductible, several strategies can lower your cost.

Generic sildenafil at the pharmacy counter without insurance runs $15 to $80 for 6 tablets of 50 mg or 100 mg, depending on the pharmacy. Costco and select independent pharmacies tend to offer the lowest cash prices. Pill splitting is a physician-approved strategy when clinically appropriate: a 100 mg tablet split in half yields two 50 mg doses at the cost of one tablet. The FDA-approved tablets are scored for splitting [3].

Manufacturer savings cards do not apply to generic sildenafil (they target brand products), but pharmacy discount programs through GoodRx, RxSaver, and similar platforms can reduce the cash price below $10 for a 6-tablet fill at participating pharmacies.

Telehealth-based prescribing services, including HealthRX, provide sildenafil prescriptions with transparent pricing and home delivery. This model eliminates the pharmacy markup and the insurance billing complexity. For men whose BCBSAZ plan excludes ED drugs, telehealth pricing is often the most predictable and lowest-cost route.

The VA health system covers sildenafil for veterans with a service-connected condition contributing to ED. Arizona has multiple VA facilities, and eligibility should be checked through va.gov if applicable.

Sildenafil Safety and Contraindications Your Insurer Expects You to Know

BCBSAZ prior authorization forms reference specific contraindications because PDE5 inhibitors interact dangerously with certain medications. Concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) with sildenafil can cause severe, potentially fatal hypotension [3]. This is an absolute contraindication.

Alpha-blockers such as tamsulosin and doxazosin require dose adjustment and a 4-hour separation window from sildenafil to avoid symptomatic hypotension [3]. Men taking riociguat (Adempas) for pulmonary hypertension must not use sildenafil for ED.

The most common side effects of sildenafil reported in clinical trials were headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and abnormal vision including blue tinge (3%) [11]. These side effects are dose-dependent and typically resolve within 4 to 6 hours.

The FDA issued a 2007 label update noting rare reports of sudden sensorineural hearing loss associated with PDE5 inhibitors [13]. The incidence remains extremely low and causality has not been definitively established, but patients should discontinue use and seek evaluation if sudden hearing changes occur.

Men with cardiovascular disease should undergo risk stratification before starting a PDE5 inhibitor. The Princeton III Consensus Panel recommends that men with low cardiovascular risk (able to perform exercise equivalent to 3 to 5 METs without symptoms) can safely use PDE5 inhibitors, while intermediate- or high-risk patients require further cardiac evaluation first [14].